Siemens Healthineers, the healthcare services subsidiary of German tech giant Siemens, is to construct a £250m ($314m) facility in the UK for the design and manufacture of MRI superconducting magnets.

Located in the city of Oxford, the 56,000sqm facility will create technology that helps to reduce the amount of helium needed for MRI machines, improving efficiency and sustainability. Replacing an old facility nearby, it will house a research and development hub for new technologies and will be carbon neutral.

The new site will support more than 1,300 jobs, including over 600 from the existing Siemens Healthineers facility. Among the roles will be physicists, engineers, technicians and specialized support staff.

The plant is expected to open in 2026.

Bernd Montag, CEO of Siemens Healthineers, said: “MRI technology plays a vital role in diagnosing disease, helping patients to get healthy and stay healthy. As a world leader in medical imaging, we are very proud to open the next chapter of our history here in Oxford.

“This factory will be the global centre for our innovative low-helium magnet technology, meaning we consume far less of a scarce natural resource and enable access to MRIs for many more patients.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.